Global law firm Greenberg Traurig, LLP represented NeoImmuneTech, Inc., a clinical-stage T cell-focused biopharmaceutical company, in connection with its initial public offering (IPO) on the Korea…
(PRWeb April 01, 2021)
Read the full story at https://www.prweb.com/releases/greenberg_traurig_represents_neoimmunetech_inc_in_kosdaq_ipo/prweb17831937.htm